Erratum: LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling (Nature (2013) 499 (306-311) doi:10.1038/nature12345);LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling

Nature

Volumn 499, Issue 7458, 2013, Pages 306-311

  Wang, Xiaomeng ^a   Abraham, Sabu ^a   McKenzie, Jenny A G ^a   Jeffs, Natasha ^a   Swire, Matthew ^a   Tripathi, Vineeta B ^a   Luhmann, Ulrich F O ^a   Lange, Clemens A K ^a,b,c   Zhai, Zhenhua ^d   Arthur, Helen M ^d   Bainbridge, James W B ^a,b   Moss, Stephen E ^a   Greenwood, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF FREIBURG   (Germany)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LRG1 PROTEIN; MEMBRANE PROTEIN; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIBODY; DISEASE; GENE EXPRESSION; PATHOGENICITY; PATHOLOGY; RODENT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOLATION PROCEDURE; MICROVASCULATURE; MODULATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RETINA DISEASE; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; UPREGULATION; VASCULAR DISEASE; WESTERN BLOTTING;

EID: 84880427962     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12641     Document Type: Erratum

References (46)

1. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. & Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309 (1989).
2. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996).
3. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
4. Holderfield, M. T. & Hughes, C. C. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-b in vascular morphogenesis. Circ. Res. 102, 637-652 (2008).
5. Chung, A. S. & Ferrara, N. Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Biol. 27, 563-584 (2011).
6. Carmeliet, P. & Jain, R. K. Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307 (2011).
7. Pardali, E., Goumans, M. J.&ten Dijke, P. Signaling bymembers of the TGF-β family in vascular morphogenesis and disease. Trends Cell Biol. 20, 556-567 (2010).
8. Goumans, M. J., Liu, Z. & ten Dijke, P. TGF-β signaling in vascular biology and dysfunction. Cell Res. 19, 116-127 (2009).
9. Cunha, S. I. et al. Genetic and pharmacological targeting of activin receptor-like kinase1impairs tumor growthandangiogenesis. J. Exp.Med.207,85-100(2010).
10. Cunha, S. I. & Pietras, K. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 117, 6999-7006 (2011).
11. ten Dijke, P. & Arthur, H. M. Extracellular control of TGFb signalling in vascular development and disease. Nature Rev. Mol. Cell Biol. 8, 857-869 (2007).
12. Xu, Q. et al. Vascular development in the retina and inner ear: control byNorrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116, 883-895 (2004).
13. Ye, X. et al. Norrin, Frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 139, 285-298 (2009).
14. Hackett, S. F., Wiegand, S., Yancopoulos, G. & Campochiaro, P. A. Angiopoietin-2 plays animportant role inretinal angiogenesis. J. Cell.Physiol. 192,182-187(2002).
15. Haigh, J. J. et al. Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev. Biol. 262, 225-241 (2003).
16. Zhao, J., Sastry, S. M., Sperduto, R. D., Chew, E. Y. & Remaley, N. A. Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. Ophthalmology 100, 423-428 (1993).
17. Kumar, B. et al. The distribution of angioarchitectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion. Ophthalmology 105, 424-427 (1998).
18. Rakic, J. M. et al. Placental growth factor, amember of the VEGF family, contributes to the development of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 3186-3193 (2003).
19. Takeda, A. et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460, 225-230 (2009).
20. Vande Veire, S. et al. Further pharmacological and genetic evidence for the efficacy of PIGF inhibition in cancer and eye disease. Cell 141, 178-190 (2010).
21. Sun, D., Kar, S. & Carr, B. I. Differentially expressed genes in TGF-β1 sensitive and resistant human hepatoma cells. Cancer Lett. 89, 73-79 (1995).
22. Li, X., Miyajima, M., Jiang, C. & Arai, H. Expression of TGF-βs and TGF-β type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus. Neurosci. Lett. 413, 141-144 (2007).
23. Saito, K. et al. Gene expression profiling of mucosal addressin cell adhesion molecule-11 high endothelial venule cells (HEV) and identification of a leucinerich HEV glycoprotein as a HEV marker. J. Immunol. 168, 1050-1059 (2002).
24. Spirin, K. S. et al. Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr. Eye Res. 18, 490-499 (1999).
25. Gao, B. B., Chen, X., Timothy, N., Aiello, L. P. & Feener, E. P. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J. Proteome Res. 7, 2516-2525 (2008).
26. Lebrin, F. et al. Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J. 23, 4018-4028 (2004).
27. Anderberg, C. et al. Deficiency for endoglin in tumor vasculature weakens the endothelial barrier tometastatic dissemination. J. Exp.Med. 210, 563-579(2013).
28. Mahmoud, M. et al. Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ. Res. 106, 1425-1433 (2010).
29. Bobik, A. Transforming growth factor-betas and vascular disorders. Arterioscler. Thromb. Vasc. Biol. 26, 1712-1720 (2006).
30. ten Dijke, P., Goumans, M. J. & Pardali, E. Endoglin in angiogenesis and vascular diseases. Angiogenesis 11, 79-89 (2008).
31. Ray, B. N., Lee, N. Y., How, T. & Blobe, G. C. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration. Carcinogenesis 31, 435-441 (2010).
32. Lynch, J. et al. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway. Carcinogenesis 33, 976-985 (2012).
33. Gregory, A. D., Capoccia, B. J., Woloszynek, J. R. & Link, D. C. Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes. J. Leukoc. Biol. 88, 123-131 (2010).
34. Blanks, J. C. & Johnson, L. V. Vascular atrophy in the retinal degenerative rdmouse. J. Comp. Neurol. 254, 543-553 (1986).
35. Heckenlively, J. R. et al. Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 23, 518-522 (2003).
36. McKenzie, J. A. et al. Apelin is required for non-neovascular remodelling in the retina. Am. J. Pathol. 108, 399-409 (2012).
37. Fruttiger, M. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest. Ophthalmol. Vis. Sci. 43, 522-527 (2002).
38. Abbott, N. J., Hughes, C. C., Revest, P. A. & Greenwood, J. Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J. Cell Sci. 103, 23-37 (1992).
39. Romero, I. A. et al. Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci. Lett. 344, 112-116 (2003).
40. Arnaoutova, I. & Kleinman, H. K. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nature Protocols 5, 628-635 (2010).
41. Deckers, M. et al. Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from fetal mouse bone explants. Lab. Invest. 81, 5-15 (2001).
42. Nicosia, R. F. & Ottinetti, A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab. Invest. 63, 115-122 (1990).
43. Balaggan, K. S. et al. EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV. Gene Ther. 13, 1153-1165 (2006).
44. Toma, H. S., Barnett, J. M., Penn, J. S. & Kim, S. J. Improved assessment of laserinduced choroidal neovascularization. Microvasc. Res. 80, 295-302 (2010).
45. Smith, L. E. et al. Oxygen-induced retinopathy in themouse. Invest. Ophthalmol. Vis. Sci. 35, 101-111 (1994).
46. Connor, K. M. et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nature Protocols 4, 1565-1573 (2009).